Cision PR Newswire

Celltrion to Present New Analyses of ZYMFENTRA® (infliximab-dyyb) in Crohn’s Disease and Ulcerative Colitis at ACG 2026

New data show favorable outcomes with subcutaneous infliximab following intravenous infliximab interruption, regardless of prior antibody status, in adult patients with moderate to...

Advancing Circular Economy: Sorbent Tissues Drive Sustainable Solutions in Australia

JAKARTA, Indonesia, April 7, 2025 /PRNewswire/ -- The Australian government recently introduced the Circular Economy Framework, a strategic initiative designed to boost sustainability and...

The Phase III Study Data of Stapokibart for Seasonal Allergic Rhinitis Published in Nature Medicine

CHENGDU, China, April 6, 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" or the "Company") today announced that the prestigious medical journal Nature Medicine...